FindTrial
Sign In

Efficacy of intravenous iron therapy for pregnancy with iron deficiency anaemia

Intravenous versus oral iron therapy in iron deficiency anaemia in pregnancy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2009/091/001077
Enrollment
100
Registered
2010-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Parenteral iron Sucrose: Iron sucrose calculated based on Hb level Control Intervention1: Oral iron- ferrous fumarate: 300 mg bd i month

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women 14-32 weeks of gestation Hb <10.5gm% -> 7gm%

Exclusion criteria

Exclusion criteria: Women with preexisting illness- chronic renal disease, inflammatory bowel disease suspected acute infection Severe anemia requiring blood transfusion

Design outcomes

Primary

MeasureTime frame
Improvement in blood parameters- Hb, reticlocyte response, Serm Ferritin Clinical improvement if anyTimepoint: Reticulocyte response 14 days after starting therapy Other parameters - 30 days after initiation of therapy and at 38 weeks of gestation / delivery—

Secondary

MeasureTime frame
Baby weight, Hb of Baby Postnatal Hb of motherTimepoint: At and after delivery—

Countries

India

Contacts

Public ContactDr Neeru Syal

Manipal University

lavanya.rai@manipal.edu0820- 2922025

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026